Zobrazeno 1 - 10
of 40
pro vyhledávání: '"Ivana, Ćelap"'
Autor:
Marija Fabijanec, Andrea Hulina-Tomašković, Mario Štefanović, Donatella Verbanac, Ivana Ćelap, Anita Somborac-Bačura, Marija Grdić Rajković, Alma Demirović, Snježana Ramić, Božo Krušlin, Lada Rumora, Andrea Čeri, Martha Koržinek, József Petrik, Neven Ljubičić, Neven Baršić, Karmela Barišić
Publikováno v:
International Journal of Molecular Sciences, Vol 25, Iss 15, p 8156 (2024)
Specific markers for colorectal cancer (CRC), preceded by colorectal adenoma (pre-CRC), are lacking. This study aimed to investigate whether microRNAs (miR-19a-3p, miR-92a-3p, miR-193a-3p, and miR-210-3p) from tissues and exosomes are potential CRC b
Externí odkaz:
https://doaj.org/article/c4d2976ed9544eca805459a8a80bcb06
Autor:
József Petrik, Donatella Verbanac, Marija Fabijanec, Andrea Hulina-Tomašković, Andrea Čeri, Anita Somborac-Bačura, Roberta Petlevski, Marija Grdić Rajković, Lada Rumora, Božo Krušlin, Mario Štefanović, Neven Ljubičić, Neven Baršić, Antonija Hanžek, Luka Bočkor, Ivana Ćelap, Alma Demirović, Karmela Barišić
Publikováno v:
International Journal of Molecular Sciences, Vol 23, Iss 21, p 13582 (2022)
Colorectal cancer (CRC) is the third most common cancer worldwide. The high mortality from CRC is mainly related to metastasis affecting distant organs and their function. Dissemination of tumor cells from the primary tumor and hematogeneous spread a
Externí odkaz:
https://doaj.org/article/257452d2c4e0401b8e3d61de073dfb0c
Publikováno v:
Acta Pharmaceutica
Volume 72
Issue 4
Volume 72
Issue 4
Direct oral anticoagulants (DOACs) represent a new generation of drugs that have been increasingly used in the prevention and treatment of thromboembolic states. According to the mechanism of anticoagulant action, DOACs are divided into two groups: d
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.
Autor:
Donatella Verbanac, Andrea Čeri, Iva Hlapčić, Mehdi Shakibaei, Aranka Brockmueller, Božo Krušlin, Neven Ljubičić, Neven Baršić, Dijana Detel, Lara Batičić, Lada Rumora, Anita Somborac-Bačura, Mario Štefanović, Ivana Ćelap, Alma Demirović, Roberta Petlevski, József Petrik, Marija Grdić Rajković, Andrea Hulina-Tomašković, Ivana Rako, Luciano Saso, Karmela Barišić
Publikováno v:
International Journal of Molecular Sciences, Vol 22, Iss 9, p 4327 (2021)
Drug-specific therapeutic approaches for colorectal cancer (CRC) have contributed to significant improvements in patient health. Nevertheless, there is still a great need to improve the personalization of treatments based on genetic and epigenetic tu
Externí odkaz:
https://doaj.org/article/ef5a050624dc44a5945798f9fd1578f6
Autor:
Palčić Marija, Gomerčić, Hana, Matijaca, Ivan, Kruljac, Lucija, Vusić, Vedran, Hostić, Luka, Vrbanić, Mrsić, Fanika, Radovan, Zrilić, Ivana, Ćelap, Petar, Gaćina
Publikováno v:
Biochemia Medica
Volume 33
Issue 2
Volume 33
Issue 2
IntroductionTocilizumab is used in patients with severe COVID-19 pneumonia and high concentration of IL-6. We studied potential prognostic role of neutrophil and lymphocyte count regarding tocilizumab treatment. Materials and methodsWe enrolled 31 pa
Autor:
Mario Štefanović, Nora Nikolac Gabaj, Lovorka Đerek, Marijana Miler, Vedran Tomašić, Joško Mitrović, Alen Bišćanin, Nada Vrkić, Jadranka Morović-Vergles, Simeon Grazio, Ivana Ćelap
Publikováno v:
Rheumatology International. 41:2195-2203
The hypothesis of the study was that polymorphisms in promoter regions -238 and -308 of TNF-α could be associated with different clinical outcomes in inflammatory bowel diseases (IBD) and immune- mediated rheumatic diseases (IMRD). The aim was to ex
Autor:
Sandra Margetić, Ivana Ćelap, Arijana Lovrenčić Huzjan, Marijana Bosnar Puretić, Sandra Šupraha Goreta, Anesa Čajević Glojnarić, Diana Delić Brkljačić, Pavao Mioč, Job Harenberg, Svetlana Hetjens, Christel Weiss
In certain clinical situations, it is necessary to determine whether clinically relevant plasma levels of direct oral anticoagulants (DOACs) are present. We examined whether qualitative testing of DOACs in urine samples can exclude DOAC plasma concen
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::887a6e6d5ad8403c13a4b2bfe8f86969
https://doi.org/10.1055/a-1753-2748
https://doi.org/10.1055/a-1753-2748
Autor:
Lara Milevoj Kopčinović, Ines Vukasović, Manuela Miletić, Snježana Hrabrić Vlah, Marija Siter Kuprešanin, Mila Lovrić, Marija Miloš, Marija Kocijančić, Helena Čičak, Ivana Ćelap, Adriana Bokulić, Gordana Juričić
Publikováno v:
Biochemia Medica
Volume 32
Issue 2
Volume 32
Issue 2
Introduction The aim of this study was to screen practices used in verification procedures for methods/analysers among medical biochemistry laboratories (MBLs) in Croatia. We hypothesized that these procedures differ widely from laboratory to laborat
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::a778cb95385e395103a0b3f16e5c5bb0
https://doi.org/10.11613/bm.2022.020703
https://doi.org/10.11613/bm.2022.020703